-
Mashup Score: 8Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - 2 year(s) ago
Abstract Sodium glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and chronic heart failure. SGLT2 inhibitor…
Categories: Cardiologists, Latest HeadlinesTweet
ISGLT2 EN INFARTO AGUDO DE MIOCARDIO🤔 Revisión @JACCJournals ✔️Por sus mecanismos de acción, debería haber beneficio en este subgrupo de pacientes ✔️Estudios ongoing #iSGLT #STEMI @DLBHATTMD 🆓https://t.co/mflIqsSAmH https://t.co/4lZ62O8E4n